NEW ON THE MARKET
Semaglutide (OZEMPIC) and other GLP-1 agonists in type 2 diabetes
Romosozumab (EVENITY) for postmenopausal osteoporosis
THERAPY FROM A CRITICAL VIEWPOINT
ISCHEMIA trial: invasive or conservative treatment in stable coronary artery disease? (short version)
Varicella-zoster virus reactivation after vaccination with SHINGRIX? free article
Ranitidine (e.g. RANITIC) withdrawn from the market in the USA
Ingenol mebutate (PICATO): approval withdrawn
CURRENT ADR NETWORK REPORT
Pruritus with new oral anticoagulants
Severe liver damage with pirfenidone (ESBRIET)
Fluorouracil cytostatics – screen for enzyme deficiency
e a-t ON THE INTERNET
Relocate production of drugs back to Germany and Europe respectively?
Chloroquine and hydroxychloroquine in COVID-19?
ISCHEMIA trial: invasive or conservative treatment in stable coronary artery disease? (long version)